Matthew A. Coelho

机构：Wellcome Sanger Institute, Open Targets · ORCID：0000-0003-3737-2468

发表论文 71 篇 · 总被引 2282 次 · h-index 14

代表论文

• Base editing screens define the genetic landscape of cancer drug resistance mechanisms (2024 · Nature Genetics · 被引 63)
• Breaking barriers: we need a multidisciplinary approach to tackle cancer drug resistance (2025 · BJC Reports · 被引 34)
• CRISPR screens in the context of immune selection identify CHD1 and MAP3K7 as mediators of cancer immunotherapy resistance (2026 · Cell Reports Medicine · 被引 1)
• On-target mutations confer resistance to WRN helicase inhibitors in Microsatellite Unstable Cancer Cells (2025 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 1)
• Abstract 420: On-target mutations confer resistance to WRN helicase inhibitors in Microsatellite Unstable Cancer Cells (2025 · Cancer Research · 被引 1)
• Table S2 from Novel WRN Helicase Inhibitors Selectively Target Microsatellite-Unstable Cancer Cells (2026)